Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,467 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.
Hamanishi J, Mandai M, Iwasaki M, Okazaki T, Tanaka Y, Yamaguchi K, Higuchi T, Yagi H, Takakura K, Minato N, Honjo T, Fujii S. Hamanishi J, et al. Among authors: fujii s. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3360-5. doi: 10.1073/pnas.0611533104. Epub 2007 Feb 21. Proc Natl Acad Sci U S A. 2007. PMID: 17360651 Free PMC article.
PEP-19 overexpression in human uterine leiomyoma.
Kanamori T, Takakura K, Mandai M, Kariya M, Fukuhara K, Kusakari T, Momma C, Shime H, Yagi H, Konishi M, Suzuki A, Matsumura N, Nanbu K, Fujita J, Fujii S. Kanamori T, et al. Among authors: fujii s. Mol Hum Reprod. 2003 Nov;9(11):709-17. doi: 10.1093/molehr/gag088. Mol Hum Reprod. 2003. PMID: 14561813
Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better.
Noda K, Ohashi Y, Sugimori H, Ozaki M, Niibe H, Ogita S, Kohno I, Hasegawa K, Kikuchi Y, Takegawa Y, Fujii S, Tanaka K, Ochiai K, Kita M, Fujiwara K. Noda K, et al. Among authors: fujii s. Gynecol Oncol. 2006 Jun;101(3):455-63. doi: 10.1016/j.ygyno.2005.11.006. Epub 2005 Dec 19. Gynecol Oncol. 2006. PMID: 16360199 Clinical Trial.
3,467 results